Particularly in light of the increased therapeutic options, early detection of RA-ILD is associated with better outcome.<h4>Methods</h4>We included 214 consecutive patients with diagnosed RF- and ACPA-positive RA in our prospective study. This evidence concerns the gene PRTN3 and rheumatoid arthritis.